Live webinar: Pharmacotherapy for overweight and obesity

Almost two thirds of adults in Australia live with overweight or obesity, and excess weight is the second leading contributor to Australia’s health burden.1 Lifestyle and behavioural interventions are the cornerstone of treatment in obesity however only a minority of people experience sustainable, long-term weight loss with those interventions alone.2 Australian and international obesity management guidelines therefore recommend a multicomponent approach to obesity care that includes pharmacotherapies in selected patients.3,4

Presented by GP Conjoint A/Prof Chee Khoo, this webinar reviews latest developments in weight loss pharmacotherapy and explores practical considerations around using medications as an adjunct to healthy behaviour change in the long-term management of overweight and obesity.

Date:Thursday, 7 November 2024
7:00pm - 8:30pm AEDT
6.00pm - 7.30pm AEST
6:30pm - 8:00pm ACDT
5:30pm - 7.00pm ACST
4:00pm - 5:30pm AWST

Duration: 1.5 hours

Professional development: CPD Total 1.5hrs (Educational Activities 1hr Reviewing Performance 0.5hr)

Learning outcomes:

By completing this learning activity, participants will be able to:

  • Outline the health risks and comorbidities associated with overweight and obesity and the evidence for improved health outcomes with weight loss.
  • Recognise the critical role of lifestyle change in obesity management.
  • Describe mechanisms of action, efficacy, and safety profiles of anti-obesity medications and discuss their role in obesity care.
  • Provide evidence-based advice to patients enquiring about weight-loss medications.
  • Evaluate patient-specific factors that may influence the choice of anti-obesity medications.

 

Presented by Conjoint A/Prof Chee Khoo

Conjoint Associate Professor Chee Khoo M.B.,B.S. Hons.

An educator with a special interest in chronic disease, Conjoint A/Prof Khoo has been a practicing solo GP in Ingleburn since 1990. He is the Chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU). He is a member of the RACGP’s Specific Interest Groups in Diabetes and Obesity Management and the Editor-in-chief at GPVoice.com.au

This session is sponsored by Eli Lilly.

References:

  1. Walmsley R, Sumithran P. Current and emerging medications for the management of obesity in adults. Med J Aust. 2023 Apr 3;218(6):276-283.
  2. Lingvay, Ildiko et al. Obesity in adults. The Lancet 2024; 404(10456):972-987.
  3. Markovic TP et al. The Australian Obesity Management Algorithm: A simple tool to guide the management of obesity in primary care. Obes Res Clin Pract. 2022 Sep-Oct;16(5):353-363.
  4. Wharton S, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020 Aug 4;192(31):E875-E891.
RELX Group plc